ArticleCancer medicine2014

Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.

Taofeek K Owonikoko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.